ArticleJournal of experimental & clinical cancer research : CR2018

Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway.

Yulin Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.